These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 326460
1. Amelioration of bendrofluazide-induced hypokalemia by timolol. Hettiarachchi J, Ramsay LE, Davies DL, Fraser R, Watson WS. Clin Pharmacol Ther; 1977 Jul; 22(1):58-62. PubMed ID: 326460 [Abstract] [Full Text] [Related]
2. Timolol and bendrofluazide in the management of hypertension in general practice. Wheatley D. Eur J Clin Pharmacol; 1978 Dec 18; 14(5):319-24. PubMed ID: 365544 [Abstract] [Full Text] [Related]
3. A hospital out-patient study of timolol/bendrofluazide combination ('Prestim') in essential hypertension. Kubik MM. Curr Med Res Opin; 1980 Dec 18; 7(1):47-54. PubMed ID: 7428413 [Abstract] [Full Text] [Related]
4. A crossover comparison of a timolol/bendrofluazide combination and methyldopa in essential hypertension. Spira M. Curr Med Res Opin; 1977 Dec 18; 5(3):252-7. PubMed ID: 162662 [No Abstract] [Full Text] [Related]
7. Timolol and bendroflumethiazide in the treatment of hypertension. Karatzas NB, Papazachos G, Clouva P, Tsaknakis T. J Int Med Res; 1979 Dec 18; 7(3):215-20. PubMed ID: 378730 [No Abstract] [Full Text] [Related]
9. A multi-centre general practice study on the use of a timolol/bendrofluazide combination ('Prestim') in the management of hypertension: preliminary report. Langrick AF, Head AC. Curr Med Res Opin; 1981 Jun 18; 7(4):268-75. PubMed ID: 7226875 [Abstract] [Full Text] [Related]
10. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination. Benjamin N, Phillips RJ, Robinson BF. Eur J Clin Pharmacol; 1988 Jun 18; 34(3):249-53. PubMed ID: 3294021 [Abstract] [Full Text] [Related]
14. Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim'). Head AC, Marsh BT, Fairey IT. Curr Med Res Opin; 1987 Jun 18; 10(8):562-5. PubMed ID: 3315469 [Abstract] [Full Text] [Related]
16. Epinephrine-induced hypokalemia: the role of beta adrenoceptors. Reid JL, Whyte KF, Struthers AD. Am J Cardiol; 1986 Apr 25; 57(12):23F-27F. PubMed ID: 3010693 [Abstract] [Full Text] [Related]
17. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide]. Cospite M, Ferrara F, Raimondi F, Lo Presti T, Ballo M, Milio G, Meli F. Clin Ter; 1981 Sep 30; 98(6):617-26. PubMed ID: 7026143 [No Abstract] [Full Text] [Related]
18. Short- and long-term therapy of mild essential hypertension with timolol. Harris FJ, Tonkin M, Pratt C, DeMaria AN, Amsterdam EA, Mason DT. Clin Pharmacol Ther; 1981 Dec 30; 30(6):765-72. PubMed ID: 7030579 [Abstract] [Full Text] [Related]
19. The effect of oral potassium supplements on plasma potassium in normokalaemic and hypokalaemic patients. Arif MA, Eaton S. J Pak Med Assoc; 1977 Nov 30; 27(11):424-6. PubMed ID: 417199 [Abstract] [Full Text] [Related]
20. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension. Wilcox RG, Mitchell JR. Br Med J; 1977 Aug 27; 2(6086):547-50. PubMed ID: 329948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]